Nasdaq
AKBA
Akebia Therapeutics, Inc.
- Health Care
- Listed 2014
- 1 day
- −26.0%
- 1 month
- −29.8%
- 1 year
- −74.8%
$0.9544 · Mkt cap $256M
At the 6 Aug 2026 close
Nasdaq
Akebia Therapeutics, Inc.
$0.9544 · Mkt cap $256M
At the 6 Aug 2026 close
Akebia Therapeutics, Inc. trades under the ticker AKBA on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $256M. The last closing price was $0.9544, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −74.8%, and −29.8% over the past month. Returns are price returns and exclude dividends.
This page exists because AKBA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.